GSK · 1 day ago
Executive Director, Oncology MDT Biomarker Lead
Collegeville, PA
Full-time
Hybrid
Director/Executive
$243K/yr - $405K/yr
15+ years expGSK is a global biopharma company committed to improving lives through innovative science and transformative medicines. As the Executive Director, MDT Biomarker Lead, you will play a pivotal role in shaping and implementing clinical biomarker strategies that inform clinical development and decision-making in collaboration with tumor-specific Medicine Development Teams.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Subject matter expert in solid tumor or haematological tumor biology, disease progression and treatment options; accountable for the strategic design and oversight of implementation of Biomarker strategies associated with disease modalities related to drug development programs
Leading asset and / or tumor-specific Biomarker Matrix teams to develop and execute clinical biomarker strategies for oncology programs in collaboration with internal and external stakeholders and with input from disease area teams
Providing input to clinical teams on biomarker-related elements of study trial design and conduct
Single point accountable person for Clinical and Translational biomarker team at the MDT. Aligns biomarker strategy with TMP and leads interactions at the MDT(s), study teams and Protocol Review Forum; representing the MDTs at governance where needed
Managing budgets and resources to deliver biomarker strategies effectively
Working with Translational Research teams to ensure alignment of preclinical and clinical biomarker strategies
Partnering with internal technology groups, Contract Research Organisations and collaborators to deliver clinically validated biomarker assays into clinical studies
Collaborating with Diagnostic leads to implement diagnostic strategies for validation, and regulatory approval of predictive biomarkers
Ensuring alignment of biomarker outputs with data management, statistics, and modelling/simulation requirements
As required, supporting the expansion of mechanism and disease understanding to generate insights that can be leveraged in indication expansion and marketing
Enabling matrix team deliverables by ensuring the appropriate evaluation of state-of-the art platform technologies and incorporating innovative biomarkers into translational medicine plans
Responsible for collaboration with clinical biomarker labs, clinical pharmacology leads and diagnostic lead and incorporating their input into clinical biomarker strategies
Qualification
Required
PhD in Oncology, Clinical Biomarkers, or Translational Research
Extensive (>15 years) experience in Oncology clinical biomarkers and translational research within clinical development
Experience in leading cross-functional teams and delivering strategic biomarker plans
Experience in interpreting clinical biomarker data and assessing innovative platforms and cutting-edge biomarker technologies and their application in clinical trials
Experience in senior stakeholder engagement supporting decision-making in drug development
Preferred
Experience in global matrix leadership across multiple locations
Familiarity with regulatory processes for diagnostics and predictive biomarkers
Ability to anticipate future challenges and innovate solutions in biomarker strategies
Excellent communication, problem solving, and influencing skills
Benefits
Annual bonus
Eligibility to participate in our share based long term incentive program
Health care and other insurance benefits (for employee and family)
Retirement benefits
Paid holidays
Vacation
Paid caregiver/parental and medical leave
Company
GSK
We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia
10001+ employees
H1B Sponsorship
GSK has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (45)
2024 (56)
2023 (54)
2022 (53)
2021 (54)
2020 (72)
Funding
Current Stage
Public CompanyTotal Funding
$25.51MKey Investors
CARB-X
2021-03-02Grant· $18M
2020-09-23Grant· $7.51M
1978-01-13IPO
Leadership Team
Julie Brown
CFO
Mike Elmore
SVP & Chief Information Security Officer, GSK
Recent News
EIN Presswire
2025-11-24
Company data provided by crunchbase